Although plasma GFAP levels showed a trend toward improved classification of disease severity, the difference compared with plasma NfL levels did not reach statistical significance (p = 0.55).
← all excerpts
Plasma glial fibrillary acidic protein (GFAP) is a biomarker for central nervous system involvement in infantile-onset Pompe disease.
1
—
—